These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22515519)

  • 1. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
    Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
    de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
    PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline kinase inhibition in rheumatoid arthritis.
    Guma M; Sanchez-Lopez E; Lodi A; Garcia-Carbonell R; Tiziani S; Karin M; Lacal JC; Firestein GS
    Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery.
    Zech SG; Kohlmann A; Zhou T; Li F; Squillace RM; Parillon LE; Greenfield MT; Miller DP; Qi J; Thomas RM; Wang Y; Xu Y; Miret JJ; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2016 Jan; 59(2):671-86. PubMed ID: 26700752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK-mediated signalling.
    Klobučar M; Grbčić P; Pavelić SK; Jonjić N; Visentin S; Sedić M
    Biochem Biophys Res Commun; 2018 Sep; 503(2):843-848. PubMed ID: 29920241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
    Zimmerman T; Moneriz C; Diez A; Bautista JM; Gómez Del Pulgar T; Cebrián A; Lacal JC
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5878-88. PubMed ID: 24041883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.
    Mazarico JM; Sánchez-Arévalo Lobo VJ; Favicchio R; Greenhalf W; Costello E; Carrillo-de Santa Pau E; Marqués M; Lacal JC; Aboagye E; Real FX
    Mol Cancer Ther; 2016 Feb; 15(2):323-33. PubMed ID: 26769123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
    Estévez-Braun A; Ravelo AG; Pérez-Sacau E; Lacal JC
    Clin Transl Oncol; 2015 Jan; 17(1):74-84. PubMed ID: 25472447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.
    Ramírez de Molina A; Sarmentero-Estrada J; Belda-Iniesta C; Tarón M; Ramírez de Molina V; Cejas P; Skrzypski M; Gallego-Ortega D; de Castro J; Casado E; García-Cabezas MA; Sánchez JJ; Nistal M; Rosell R; González-Barón M; Lacal JC
    Lancet Oncol; 2007 Oct; 8(10):889-97. PubMed ID: 17851129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline kinase alpha depletion selectively kills tumoral cells.
    Bañez-Coronel M; Ramírez de Molina A; Rodríguez-González A; Sarmentero J; Ramos MA; García-Cabezas MA; García-Oroz L; Lacal JC
    Curr Cancer Drug Targets; 2008 Dec; 8(8):709-19. PubMed ID: 19075594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.
    Arlauckas SP; Popov AV; Delikatny EJ
    Prog Lipid Res; 2016 Jul; 63():28-40. PubMed ID: 27073147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
    Vijayan Y; Lankadasari MB; Harikumar KB
    Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical characterization of RSM-932A, a novel anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
    Lacal JC; Campos JM
    Mol Cancer Ther; 2015 Jan; 14(1):31-9. PubMed ID: 25487918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy for detection of choline kinase inhibition in the treatment of brain tumors.
    Kumar M; Arlauckas SP; Saksena S; Verma G; Ittyerah R; Pickup S; Popov AV; Delikatny EJ; Poptani H
    Mol Cancer Ther; 2015 Apr; 14(4):899-908. PubMed ID: 25657334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells.
    Zheng H; Liu A; Liu B; Li M; Yu H; Luo X
    Cancer Lett; 2010 Nov; 297(1):117-25. PubMed ID: 20554106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
    White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
    J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer.
    Mahdy AE; Cheng JC; Li J; Elojeimy S; Meacham WD; Turner LS; Bai A; Gault CR; McPherson AS; Garcia N; Beckham TH; Saad A; Bielawska A; Bielawski J; Hannun YA; Keane TE; Taha MI; Hammouda HM; Norris JS; Liu X
    Mol Ther; 2009 Mar; 17(3):430-8. PubMed ID: 19107118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.